Jennifer Leigh-stewar Ghand

Array ( [id] => 1088961 [patent_doc_number] => 06828138 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-12-07 [patent_title] => 'Recombinant sendai virus vector including a gene encoding a chemokine' [patent_app_type] => B1 [patent_app_number] => 09/132521 [patent_app_country] => US [patent_app_date] => 1998-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4814 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/828/06828138.pdf [firstpage_image] =>[orig_patent_app_number] => 09132521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1372482 [patent_doc_number] => 06566579 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-20 [patent_title] => 'I-Sce I induced gene replacement and gene conversion in embryonic stem cells' [patent_app_type] => B1 [patent_app_number] => 09/116834 [patent_app_country] => US [patent_app_date] => 1998-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 9 [patent_no_of_words] => 4066 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566579.pdf [firstpage_image] =>[orig_patent_app_number] => 09116834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7634564 [patent_doc_number] => 06657056 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-02 [patent_title] => 'Compounds for immunotherapy of prostate cancer and methods for their use' [patent_app_type] => B2 [patent_app_number] => 09/115453 [patent_app_country] => US [patent_app_date] => 1998-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25112 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/657/06657056.pdf [firstpage_image] =>[orig_patent_app_number] => 09115453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5848677 [patent_doc_number] => 20020133831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'METHOD FOR IDENTIFYING MUTANTS AND MOLECULES' [patent_app_type] => new [patent_app_number] => 09/114973 [patent_app_country] => US [patent_app_date] => 1998-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7381 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0133/20020133831.pdf [firstpage_image] =>[orig_patent_app_number] => 09114973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4187806 [patent_doc_number] => 06129911 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-10 [patent_title] => 'Liver stem cell' [patent_app_type] => 1 [patent_app_number] => 9/113774 [patent_app_country] => US [patent_app_date] => 1998-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 4807 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/129/06129911.pdf [firstpage_image] =>[orig_patent_app_number] => 113774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6890795 [patent_doc_number] => 20010008026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-12 [patent_title] => 'SYSTEM FOR TISSUE-RESTRICTED GENE RECOMBINATION' [patent_app_type] => new-utility [patent_app_number] => 09/104654 [patent_app_country] => US [patent_app_date] => 1998-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 19440 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20010008026.pdf [firstpage_image] =>[orig_patent_app_number] => 09104654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1081084 [patent_doc_number] => 06835867 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-12-28 [patent_title] => 'Allelic series of genomic modifications in cells' [patent_app_type] => B1 [patent_app_number] => 09/103846 [patent_app_country] => US [patent_app_date] => 1998-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12611 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 195 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/835/06835867.pdf [firstpage_image] =>[orig_patent_app_number] => 09103846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5829180 [patent_doc_number] => 20020068707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'IGA NEPHROPATHY-RELATED GENES' [patent_app_type] => new [patent_app_number] => 09/090672 [patent_app_country] => US [patent_app_date] => 1998-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14364 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068707.pdf [firstpage_image] =>[orig_patent_app_number] => 09090672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4364570 [patent_doc_number] => 06274338 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Human c-Maf compositions and methods of use thereof' [patent_app_type] => 1 [patent_app_number] => 9/086010 [patent_app_country] => US [patent_app_date] => 1998-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 25357 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274338.pdf [firstpage_image] =>[orig_patent_app_number] => 086010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1315962 [patent_doc_number] => 06608034 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-19 [patent_title] => 'Immunovectors for the intracellular and intranuclear transport' [patent_app_type] => B1 [patent_app_number] => 08/981474 [patent_app_country] => US [patent_app_date] => 1998-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 7790 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/608/06608034.pdf [firstpage_image] =>[orig_patent_app_number] => 08981474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1559353 [patent_doc_number] => 06436656 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Method for screening a test compound for potential as an immunosuppressive drug candidate' [patent_app_type] => B1 [patent_app_number] => 09/033715 [patent_app_country] => US [patent_app_date] => 1998-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 30 [patent_no_of_words] => 10243 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436656.pdf [firstpage_image] =>[orig_patent_app_number] => 09033715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1299170 [patent_doc_number] => 06623951 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-23 [patent_title] => 'HBV vectors and cells for producing the same' [patent_app_type] => B1 [patent_app_number] => 08/952674 [patent_app_country] => US [patent_app_date] => 1998-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 2374 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/623/06623951.pdf [firstpage_image] =>[orig_patent_app_number] => 08952674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7612905 [patent_doc_number] => 06902929 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-06-07 [patent_title] => 'Retroviral vectors, methods for their preparation and their use for gene transfer into CD4-positive cells' [patent_app_type] => utility [patent_app_number] => 09/380324 [patent_app_country] => US [patent_app_date] => 1998-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 6721 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/902/06902929.pdf [firstpage_image] =>[orig_patent_app_number] => 09380324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3930458 [patent_doc_number] => 05928829 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'Latex processes' [patent_app_type] => 1 [patent_app_number] => 9/031252 [patent_app_country] => US [patent_app_date] => 1998-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10271 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/928/05928829.pdf [firstpage_image] =>[orig_patent_app_number] => 031252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 985418 [patent_doc_number] => 06924146 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-08-02 [patent_title] => 'Method of constructing vectors for homologous recombination directed mutagenesis' [patent_app_type] => utility [patent_app_number] => 09/171642 [patent_app_country] => US [patent_app_date] => 1998-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5430 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 243 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/924/06924146.pdf [firstpage_image] =>[orig_patent_app_number] => 09171642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4387980 [patent_doc_number] => 06262337 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Transgenic animal with recombinant vascular endothelial growth factor B (VEGF-B DNA) and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/025701 [patent_app_country] => US [patent_app_date] => 1998-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 9146 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/262/06262337.pdf [firstpage_image] =>[orig_patent_app_number] => 025701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4093244 [patent_doc_number] => 06133503 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Mammalian artificial chromosomes and methods of using same' [patent_app_type] => 1 [patent_app_number] => 9/024472 [patent_app_country] => US [patent_app_date] => 1998-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 17338 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133503.pdf [firstpage_image] =>[orig_patent_app_number] => 024472 [rel_patent_id] =>[rel_patent_doc_number] =>)